Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy (NCT05818605)
The EXerCise traIning To rEcovery in HCM Trial
🩺 Plain-English Summary (8th-Grade Level)
The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruited and randomized on a 1:1 ratio to either moderate intensity training or usual physicial activity interventions. Patients will be followed during a period of 24 weeks and assesesments as physical examination, questionnaires, 12 lead ecg's, biomarker levels, echocardiogram, Cardiac Magnetic resonance, PET and CPET will be performed to evaluate their response to the intervention.
Who can join: Review the eligibility criteria below.
Location: University of California - San Francisco — San Francisco, California
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
- Moderate Intensity Exercise Program (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of California - San Francisco — San Francisco, California
📞 Contact the Study Coordinator
Phone: (415) 514-1125
Email: Cynthia.Partida-Higuera@ucsf.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hypertrophic Cardiomyopathy
- A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy — Rochester, Minnesota
- HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy — New Haven, Connecticut
- A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's — Rochester, Minnesota
- A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM) — San Francisco, California
- VIZ ACCESS HCM - Multi-Site Registry — Atlanta, Georgia
Explore by condition: All Hypertrophic Cardiomyopathy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.